Latest News and Press Releases
Want to stay updated on the latest news?
-
Azalea highlights Nature publication demonstrating in vivo CAR T engineering through site-specific genomic integration with durable anti-tumor activity.
-
Azalea Therapeutics launches with $82M to advance precision in vivo genome engineering, creating therapeutic cells directly inside patients.